全文获取类型
收费全文 | 28539篇 |
免费 | 1562篇 |
国内免费 | 130篇 |
专业分类
耳鼻咽喉 | 420篇 |
儿科学 | 759篇 |
妇产科学 | 550篇 |
基础医学 | 3847篇 |
口腔科学 | 1019篇 |
临床医学 | 2277篇 |
内科学 | 6425篇 |
皮肤病学 | 500篇 |
神经病学 | 2761篇 |
特种医学 | 815篇 |
外国民族医学 | 2篇 |
外科学 | 4188篇 |
综合类 | 147篇 |
一般理论 | 6篇 |
预防医学 | 2328篇 |
眼科学 | 487篇 |
药学 | 1788篇 |
1篇 | |
中国医学 | 90篇 |
肿瘤学 | 1821篇 |
出版年
2024年 | 31篇 |
2023年 | 224篇 |
2022年 | 316篇 |
2021年 | 674篇 |
2020年 | 414篇 |
2019年 | 614篇 |
2018年 | 1055篇 |
2017年 | 700篇 |
2016年 | 757篇 |
2015年 | 946篇 |
2014年 | 1025篇 |
2013年 | 1439篇 |
2012年 | 2368篇 |
2011年 | 2408篇 |
2010年 | 1215篇 |
2009年 | 909篇 |
2008年 | 2062篇 |
2007年 | 2076篇 |
2006年 | 1940篇 |
2005年 | 1833篇 |
2004年 | 1713篇 |
2003年 | 1546篇 |
2002年 | 1366篇 |
2001年 | 266篇 |
2000年 | 260篇 |
1999年 | 224篇 |
1998年 | 129篇 |
1997年 | 93篇 |
1996年 | 84篇 |
1995年 | 80篇 |
1994年 | 53篇 |
1993年 | 64篇 |
1992年 | 117篇 |
1991年 | 106篇 |
1990年 | 95篇 |
1989年 | 84篇 |
1988年 | 54篇 |
1987年 | 57篇 |
1986年 | 59篇 |
1985年 | 68篇 |
1984年 | 73篇 |
1983年 | 59篇 |
1982年 | 67篇 |
1981年 | 43篇 |
1980年 | 51篇 |
1979年 | 42篇 |
1978年 | 33篇 |
1976年 | 37篇 |
1973年 | 34篇 |
1971年 | 27篇 |
排序方式: 共有10000条查询结果,搜索用时 8 毫秒
11.
12.
13.
14.
15.
16.
Emmanuel J Favaloro Roslyn Bonar Elizabeth Duncan Susan Rodgers Katherine Marsden 《Blood coagulation & fibrinolysis》2007,18(5):441-448
The PFA-100 is a relatively new laboratory instrument, first described in 1995. There have since been numerous studies assessing its utility as a screening tool for platelet dysfunction and/or von Willebrand's disease (VWD). The PFA-100 displays variable sensitivity to different types of platelet disorders, as well as to antiplatelet medication (e.g. aspirin), with similar caveats for monitoring of primary haemostasis-promoting therapies in platelet dysfunction. There is therefore considerable uncertainty regarding its utility within this context, and we have accordingly performed an audit of usage among participants of the Royal College of Pathologists of Australasia Quality Assurance Program. Of 105 laboratories surveyed, 40 responded that they performed platelet function testing, with 26 (65%) further indicating they utilized the PFA-100. We report a wide variety of laboratory usage among these users, including numbers of tests performed [annual median (range) = 270 (15-6000)], sources of requests (clinical sources and localities), testing criteria and follow-up action. Most tests were completed within 4 h of collection, as recommended by the manufacturer, and most tests were performed as a replacement, or as a preliminary screen of platelet function (i.e. classical aggregation). Most abnormal findings, however, were attributed to antiplatelet medication such as aspirin. 相似文献
17.
Emmanuel Blot Elsie Staub 《Journal of clinical oncology》2003,21(20):3887; author reply 3887-3887; author reply 3888
18.
19.
20.
Elena Christoforou Ioannis Papassotiriou Christophille Skarmoutsou Stavros Doudounakis Alexandra Stamoulakatou Emmanuel Kanavakis 《Journal of cystic fibrosis》2005,4(3):151-156
BACKGROUND: Chronic pulmonary disease and progressive tissue hypoxia are major causes of morbidity and mortality in cystic fibrosis (CF). Normally the body adapts to tissue hypoxia by increasing the red cell mass and decreasing the Hb-O(2) affinity. These adaptations are commonly observed in patients with cyanotic heart disease and individuals living at high altitude. However, patients with CF not only have an impaired erythroid response to hypoxia, but also are frequently anaemic. METHODS: In order to evaluate erythroid marrow activity and tissue oxygenation in 37 patients with CF we measured: the haematological and blood chemistry parameters; including red cell indices, ferritin, erythropoietin (Epo) and soluble transferrin receptors (sTfR) levels; arterial blood gases, P(50) and oxygen release to the tissues (O(2)(R)) and the 2,3-BPG levels. RESULTS: The main results showed that a) patients with CF have a mild degree of tissue hypoxia which is expressed by the moderately decreased of P(50) and O(2)(R) values and the relative increase of Epo level, b) 2,3-BPG synthesis in patients with CF is normal and c) sTfR levels are significantly increased (3-fold normal) in patients with CF compared to normal controls. CONCLUSIONS: The above observations indicate that erythroid marrow activity in patients with CF is increased. 相似文献